Dendreon gains on Provenge sales

Dendreon Corp. (NASDAQ:DNDN) gained $5.95 (18%) to $39.78 on Wednesday after reporting late Tuesday that Provenge sipuleucel-T has recorded $8 million in revenue since its launch in April to treat met...